Literature DB >> 19756665

[Radiographic healing of sarcoid bone erosion].

N Blank1, C Fiehn, H-M Lorenz.   

Abstract

Sarcoidosis is a systemic granulomatous disease that primarily affects the lung and other organs. Patients with dactylitis should be screened for abnormalities of the skin, eyes and lungs. Even in patients with normal-range ACE sarcoidosis could be confirmed by tissue biopsy. Treatment with methotrexate and steroids can relieve symptoms and stabilize the disease. In refractory cases leflunomide, azathioprine, hydroxychloroquine or antibodies against TNF-alpha can be additionally administered.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19756665     DOI: 10.1007/s00393-009-0505-8

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  9 in total

1.  Sarcoidosis of hand.

Authors:  P FITZGERALD; F O MEENAN
Journal:  J Bone Joint Surg Br       Date:  1958-05

2.  Clinical images: Radiographic healing of osseous sarcoidosis.

Authors:  Gregory C Gardner; John C Hunter
Journal:  Arthritis Rheum       Date:  2005-07

3.  Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial.

Authors:  R P Baughman; D B Winget; E E Lower
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2000-03       Impact factor: 0.670

4.  An unusual case of sarcoid dactylitis.

Authors:  D Van Linthoudt; H Ott
Journal:  Br J Rheumatol       Date:  1986-05

5.  Hydroxychloroquine is effective therapy for control of cutaneous sarcoidal granulomas.

Authors:  E Jones; J P Callen
Journal:  J Am Acad Dermatol       Date:  1990-09       Impact factor: 11.527

6.  Sarcoidosis of bone.

Authors:  E Neville; L S Carstairs; D G James
Journal:  Q J Med       Date:  1977-04

7.  Sarcoid dactylitis in black South African patients.

Authors:  M R Leibowitz; A R Essop; C L Schamroth; D Blumsohn; E H Smith
Journal:  Semin Arthritis Rheum       Date:  1985-05       Impact factor: 5.532

8.  Leflunomide for chronic sarcoidosis.

Authors:  Robert P Baughman; Elyse E Lower
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2004-03       Impact factor: 0.670

9.  Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial.

Authors:  M A Judson; R P Baughman; U Costabel; S Flavin; K H Lo; M S Kavuru; M Drent
Journal:  Eur Respir J       Date:  2008-02-06       Impact factor: 16.671

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.